
pmid: 20508016
Trinity Evolution Cryopreserved Cell Viable Bone Matrix is a minimally manipulated, human cellular, and tissue-based allograft containing adult mesenchymal stem cells, osteoprogenitor cells, and a demineralized cortical component. The cancellous bone used to produce Trinity Evolution is derived from freshly recovered donor tissue by Food and Drug Administration—registered facilities and processed under aseptic conditions. Preclinical in vivo and in vitro testing as well as strict donor screening has demonstrated the safety of Trinity Evolution as well as its osteoinductive and osteogenic potential contained within a natural osteoconductive matrix.
Cryopreservation, Tissue Engineering, Osteogenesis, Bone Matrix, Humans, Transplantation, Homologous, Mesenchymal Stem Cells, Immunogenetic Phenomena, Mesenchymal Stem Cell Transplantation, Specimen Handling
Cryopreservation, Tissue Engineering, Osteogenesis, Bone Matrix, Humans, Transplantation, Homologous, Mesenchymal Stem Cells, Immunogenetic Phenomena, Mesenchymal Stem Cell Transplantation, Specimen Handling
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
